Its initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRACurrently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia, and China. Applications for approval are planned for Croatia, France, Germany, and Austria.